Dr Alastair Riddell, chairman of Feedback (LON:FDBK) tells Proactive Investor’s Andrew Scott their TexRAD Lung product could soon be available on the diagnostic imaging platform of a leading global imaging company.
Home » Feedback (FDBK) » Feedback Chairman Dr Alastair Riddell discusses TexRAD Lung and other developments with Proactive’s Andrew Scott
Dr Alastair Riddell, chairman of Feedback (LON:FDBK) tells Proactive Investor’s Andrew Scott their TexRAD Lung product could soon be available on the diagnostic imaging platform of a leading global imaging company.